Event-Driven Stocks

Cardinal Health

CAHNYSE

Other · Wholesale-Drugs, Proprietaries & Druggists' Sundries · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 1 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$222.58B$226.83B$204.98B$181.33B$162.47B$152.92B
Operating income$2.27B$1.24B$752.0M−$607.0M$472.0M−$4.10B
Net income$1.56B$852.0M$330.0M−$938.0M$611.0M−$3.70B
Total assets$53.12B$45.12B$43.35B$43.88B$44.45B$40.77B
Total liabilities——————
Equity−$2.78B−$3.21B−$2.96B−$709.0M$1.79B$1.79B
EPS (diluted)$6.45$3.45$1.26$-3.37$2.08$-12.61
Shares out.238.8M243.8M250.7M272.5M290.4M292.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
1.0%
Net margin
0.7%
Return on equity
−56.1%
Return on assets
2.9%
Return on capital (ROCE)
16.0%
Liabilities / assets
—
Debt / equity
—
Book value / share
$-11.65
Revenue growth (YoY)
−1.9%
Net income growth (YoY)
83.2%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−1.6%clean
Piotroski F-Score
6/8mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
53
/ 100
Profitability 80Growth 50Catalyst 33Earnings quality 100Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 severe● 1 warning● 3 good
  • Negative shareholder equity
  • Revenue declined year-over-year
  • Operating margin is positive
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20267.4M2.6+22.4%
Apr 30, 20266.1M3.1+3.0%
Apr 15, 20265.9M4.4-2.2%
Mar 31, 20266.0M3.1-0.4%
Mar 13, 20266.0M3.1+21.1%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Corporate family

Spin-offs from Cardinal Health (1)

From the spin-off filings we track. Follow a company to walk its own history.

Event-driven situations (4)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.